160 related articles for article (PubMed ID: 15543188)
21. Waking at night to smoke as a marker for tobacco dependence: patient characteristics and relationship to treatment outcome.
Bover MT; Foulds J; Steinberg MB; Richardson D; Marcella SW
Int J Clin Pract; 2008 Feb; 62(2):182-90. PubMed ID: 18199277
[TBL] [Abstract][Full Text] [Related]
22. Subconjunctival triamcinolone treatment for non-necrotising anterior scleritis.
Roufas A; Jalaludin B; Gaskin C; McCluskey P
Br J Ophthalmol; 2010 Jun; 94(6):743-7. PubMed ID: 20447959
[TBL] [Abstract][Full Text] [Related]
23. [Clinical characteristics of 4 cases of scleritis associated with systemic lupus erythematosus].
Wang L; Yang Y; Jia Y; Miao H; Zhou YS; Zhang XY
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1081-1085. PubMed ID: 27987518
[TBL] [Abstract][Full Text] [Related]
24. Cyclo-oxygenase inhibitors in the treatment of chronic non-infectious, non-necrotizing scleritis and episcleritis.
Kolomeyer AM; Ragam A; Shah K; Do BK; Shah VP; Chu DS
Ocul Immunol Inflamm; 2012 Aug; 20(4):293-9. PubMed ID: 22642498
[TBL] [Abstract][Full Text] [Related]
25. [Indication and effect of immunosuppression in patients with scleritis].
Heiligenhaus A; Dück N; Michel D; Hudde T; Koch J; Steuhl KP
Klin Monbl Augenheilkd; 2003 Jul; 220(7):471-80. PubMed ID: 12886507
[TBL] [Abstract][Full Text] [Related]
26. Episcleritis in childhood.
Read RW; Weiss AH; Sherry DD
Ophthalmology; 1999 Dec; 106(12):2377-9. PubMed ID: 10599674
[TBL] [Abstract][Full Text] [Related]
27. Treatment of ocular inflammatory disorders with daclizumab.
Papaliodis GN; Chu D; Foster CS
Ophthalmology; 2003 Apr; 110(4):786-9. PubMed ID: 12689903
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of subconjunctival triamcinolone for nonnecrotizing anterior scleritis.
Albini TA; Zamir E; Read RW; Smith RE; See RF; Rao NA
Ophthalmology; 2005 Oct; 112(10):1814-20. PubMed ID: 16199269
[TBL] [Abstract][Full Text] [Related]
29. Does smoking predispose to peptic ulcer relapse after eradication of Helicobacter pylori?
Chan FK; Sung JJ; Lee YT; Leung WK; Chan LY; Yung MY; Chung SC
Am J Gastroenterol; 1997 Mar; 92(3):442-5. PubMed ID: 9068465
[TBL] [Abstract][Full Text] [Related]
30. Smoking status and antithrombin therapy in patients with non-ST-segment elevation acute coronary syndrome.
Leung S; Gallup D; Mahaffey KW; Cohen M; Antman EM; Goodman SG; Harrington RA; Langer A; Aylward P; Ferguson JJ; Califf RM;
Am Heart J; 2008 Jul; 156(1):177-84. PubMed ID: 18585514
[TBL] [Abstract][Full Text] [Related]
31. A randomised, double-blind trial of topical ketorolac vs artificial tears for the treatment of episcleritis.
Williams CP; Browning AC; Sleep TJ; Webber SK; McGill JI
Eye (Lond); 2005 Jul; 19(7):739-42. PubMed ID: 15359265
[TBL] [Abstract][Full Text] [Related]
32. [Clinical features and response to systemic treatment of primary and secondary episcleritis and scleritis resistant to local treatment].
Cuchacovich T M; Pacheco P; Merino G; Gallardo P; Gatica H; Valenzuela H; Verdaguer J; Verdaguer J
Rev Med Chil; 2000 Nov; 128(11):1205-14. PubMed ID: 11347507
[TBL] [Abstract][Full Text] [Related]
33. Posterior scleritis in children: clinical features and treatment.
Cheung CM; Chee SP
Ophthalmology; 2012 Jan; 119(1):59-65. PubMed ID: 22137553
[TBL] [Abstract][Full Text] [Related]
34. Topical cyclosporine A as a steroid-sparing agent in steroid-dependent idiopathic ocular myositis with scleritis: a case report and review of the literature.
Gumus K; Mirza GE; Cavanagh HD; Karakucuk S
Eye Contact Lens; 2009 Sep; 35(5):275-8. PubMed ID: 19687744
[TBL] [Abstract][Full Text] [Related]
35. Effects of tobacco dose and length of exposure on delayed neurological deterioration and overall clinical outcome after aneurysmal subarachnoid hemorrhage.
Krishnamurthy S; Kelleher JP; Lehman EB; Cockroft KM
Neurosurgery; 2007 Sep; 61(3):475-80; discussion 480-1. PubMed ID: 17881958
[TBL] [Abstract][Full Text] [Related]
36. [Conjunctivitis, episcleritis and scleritis].
Robin H
Rev Prat; 1999 Nov; 49(18):1969-75. PubMed ID: 10626480
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of patients with scleritis for systemic disease.
Akpek EK; Thorne JE; Qazi FA; Do DV; Jabs DA
Ophthalmology; 2004 Mar; 111(3):501-6. PubMed ID: 15019326
[TBL] [Abstract][Full Text] [Related]
38. Smoking status and psychosocioeconomic outcomes of functional restoration in patients with chronic spinal disability.
McGeary DD; Mayer TG; Gatchel RJ; Anagnostis C
Spine J; 2004; 4(2):170-5. PubMed ID: 15016394
[TBL] [Abstract][Full Text] [Related]
39. Ultrasound biomicroscopy in scleritis.
Heiligenhaus A; Schilling M; Lung E; Steuhl KP
Ophthalmology; 1998 Mar; 105(3):527-34. PubMed ID: 9499786
[TBL] [Abstract][Full Text] [Related]
40. Posterior scleritis: a clinical and histological survey.
Calthorpe CM; Watson PG; McCartney AC
Eye (Lond); 1988; 2 ( Pt 3)():267-77. PubMed ID: 3402623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
